- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02223962
Effects of Physical Activity Counseling After an Exacerbation in COPD
The Effects of a Physical Activity Counseling Program Immediately After an Exacerbation in Patients With COPD.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
After signing the informed consent, the patients will be randomized into a control group, receiving usual care, or the intervention group receiving real-time feedback and physical activity counseling.
Intervention: Physical activity counseling will be provided by 3 weekly telephone contacts based on the step count from the Fitbit Ultra. In agreement with the patient and based on the step counts a patients provided, a new goal for the next week was set. The goal was to strive for the highest possible level of physical activity during one month.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Leuven, Belgique, 3000
- University Hospital Leuven
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Signed Informed Consent
- Chronic Obstructive Lung Disease (Tiff<70%)
- Hospitalized because of exacerbation
- Capable of working with electronic devices
Exclusion Criteria:
- Orthopedic/Neurologic problems making it difficult to be active
- Participation in a rehabilitation program
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Physical activity
The fitbit Ultra was used to provide real-time feedback on physical activity.
An experienced physiotherapist contacted the subjects 3 times a week to receive information about the amount of steps from the previous days.
In agreement with the patient, a new goal for the coming weeks was set and patients were motivated to achieve their individual goal.
|
Counseling about physical activity will only be provided in the intervention group by 3 weekly telephone contacts.
Based on the information the physiotherapist receives, he or she will adapt the goal (in agreement with the patient) and motivate the patient to reach the individual goal.
|
|
Comparateur placebo: Usual Care
During the hospital stay, the patients in the control group will be informed about the beneficial effects of being physically inactive.They will not receive feedback about their activities performed and will not be stimulated to become more active.
|
Counseling about physical activity will only be provided in the intervention group by 3 weekly telephone contacts.
Based on the information the physiotherapist receives, he or she will adapt the goal (in agreement with the patient) and motivate the patient to reach the individual goal.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Improvement in physical activity
Délai: 1 month
|
The Dynaport MoveMonitor, a valid device in patients with COPD, was used to accurately measure the level of physical activity.
The device was provided 3 times to the patients (baseline, after 2 weeks, after 1 month).
The amount of steps, measured by this device, was used as the outcome measure.
|
1 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Improvement in functional exercise capacity
Délai: 1 month
|
Functional exercise capacity was measured by the six minutes walking distance test (6MWD; meter).
This measurement was performed at baseline and after 1 month.
|
1 month
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- S55086
- ML8991 (Autre identifiant: University Hospital Leuven)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .